Detalles de la búsqueda
1.
Results of the compassionate program of inotuzumab ozogamicin for adult patients with relapsed or refractory acute lymphoblastic leukemia in Spain.
Eur J Haematol
; 111(3): 485-490, 2023 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-37381686
2.
Prognosis of patients with acute lymphoblastic leukaemia relapsing after allogeneic stem cell transplantation.
Eur J Haematol
; 110(6): 659-668, 2023 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-36813736
3.
Treatment of steroid-refractory chronic graft-versus-host disease with imatinib: Real-life experience of the Spanish group of hematopoietic transplantation (GETH).
Clin Transplant
; 35(5): e14255, 2021 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33595866
4.
Predicting Survival after Allogeneic Hematopoietic Cell Transplantation in Myelofibrosis: Performance of the Myelofibrosis Transplant Scoring System (MTSS) and Development of a New Prognostic Model.
Biol Blood Marrow Transplant
; 26(12): 2237-2244, 2020 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-32717433
5.
Blinatumomab and inotuzumab for B cell precursor acute lymphoblastic leukaemia in children: a retrospective study from the Leukemia Working Group of the Spanish Society of Pediatric Hematology and Oncology (SEHOP).
Br J Haematol
; 190(5): 764-771, 2020 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32314348
6.
Response to Novel Drugs before and after Allogeneic Stem Cell Transplantation in Patients with Relapsed Multiple Myeloma.
Biol Blood Marrow Transplant
; 25(9): 1703-1712, 2019 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-31054983
7.
Phase II Study of Yttrium-90-Ibritumomab Tiuxetan as Part of Reduced-Intensity Conditioning (with Melphalan, Fludarabine ± Thiotepa) for Allogeneic Transplantation in Relapsed or Refractory Aggressive B Cell Lymphoma: A GELTAMO Trial.
Biol Blood Marrow Transplant
; 23(1): 53-59, 2017 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-27771496
8.
Characterization of Chronic Graft-versus-host Disease After Haploidentical Stem Cell Transplantation With Posttransplant Cyclophosphamide: A Study on Behalf of GETH-TC.
Transplantation
; 2024 Apr 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-38685204
9.
Total body irradiation versus thiotepa/busulfan-based conditioning regimens for myeloablative allogeneic stem cell transplantation in adults with acute lymphoblastic leukemia.
Bone Marrow Transplant
; 2024 May 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-38755458
10.
Adenovirus-induced hemorrhagic cystitis after CD19-targeted chimeric antigen receptor T-cell therapy in a patient with large B-cell lymphoma.
Immunotherapy
; 15(16): 1369-1374, 2023 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-37718888
11.
Results of haploidentical transplant in patients with donor-specific antibodies: a survey on behalf of the Spanish Group of Hematopoietic Transplant and Cell Therapy.
Front Immunol
; 14: 1165759, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37304258
12.
Role of allogeneic hematopoietic cell transplant for relapsed/refractory aggressive B-cell lymphomas in the CART era.
Bone Marrow Transplant
; 58(6): 673-679, 2023 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-36918682
13.
Allogeneic Hematopoietic Stem Cell Transplantation in Transformed Follicular Lymphoma (tFL): Results of a Retrospective Multicenter Study from GELTAMO/GETH-TC Spanish Groups.
Cancers (Basel)
; 14(22)2022 Nov 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-36428762
14.
Allogeneic Stem Cell Transplantation in Mantle Cell Lymphoma; Insights into Its Potential Role in the Era of New Immunotherapeutic and Targeted Therapies: The GETH/GELTAMO Experience.
Cancers (Basel)
; 14(11)2022 May 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-35681653
15.
Post-Transplantation Cyclophosphamide After HLA Identical Compared to Haploidentical Donor Transplant in Acute Myeloid Leukemia: A Study on Behalf of GETH-TC.
Transplant Cell Ther
; 28(4): 204.e1-204.e10, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-35108627
16.
Allogeneic stem cell transplantation as a curative option in relapse/refractory diffuse large B cell lymphoma: Spanish multicenter GETH/GELTAMO study.
Bone Marrow Transplant
; 56(8): 1919-1928, 2021 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-33767400
17.
Vitamin D Modifies the Incidence of Graft-versus-Host Disease after Allogeneic Stem Cell Transplantation Depending on the Vitamin D Receptor (VDR) Polymorphisms.
Clin Cancer Res
; 25(15): 4616-4623, 2019 08 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31043390
18.
Hidden myelodysplastic syndrome (MDS): A prospective study to confirm or exclude MDS in patients with anemia of uncertain etiology.
Int J Lab Hematol
; 41(1): 109-117, 2019 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-30290085
19.
Reduced intensity conditioning increases risk of severe cGVHD: identification of risk factors for cGVHD in a multicenter setting.
Med Oncol
; 35(6): 79, 2018 Apr 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-29696461
20.
Correction: Role of allogeneic hematopoietic cell transplant for relapsed/refractory aggressive B-cell lymphomas in the CART era.
Bone Marrow Transplant
; 58(6): 738, 2023 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-37076611